Measuring and Modeling of Melt Viscosity for Drug Polymer Mixtures

Vincent Kimmel,Enrico Ercolin,Robin Zimmer,Muhammet Yörük,Judith Winck,Markus Thommes

DOI: https://doi.org/10.3390/pharmaceutics16030301

IF: 6.525

2024-02-22

Pharmaceutics

Abstract:Melt viscosity is an essential property in pharmaceutical processes such as mixing, extrusion, fused deposition modeling, and melt coating. Measuring and modeling of the melt viscosity for drug/polymer mixtures is essential for optimization of the manufacturing process. In this work, the melt viscosity of nine formulations containing the drug substances acetaminophen, itraconazole, and griseofulvin, as well as the pharmaceutical polymers Eudragit EPO, Soluplus, and Plasdone S-630, were analyzed with a rotational and oscillatory rheometer. The shear rate, temperature, and drug fraction were varied systematically to investigate their influence on viscosity. The results for the pure polymers showed typical shear-thinning behavior and are fundamental for modeling with the Carreau and Arrhenius approaches. The investigations of the viscosity of the drug/polymer mixtures resulted in a plasticizing or a filler effect, depending on the type of drug and the phase behavior. A drug shift factor was proposed to model the change in viscosity as a function of the drug fraction. On this basis, a universal model to describe the melt viscosity of drug/polymer mixtures was developed, considering shear rate, temperature, and drug fraction.

pharmacology & pharmacy

What problem does this paper attempt to address?

This paper attempts to solve the problems of melt viscosity measurement and modeling of pharmaceutical polymer mixtures. Specifically, the author focuses on the changes in melt viscosity of drug - polymer mixtures under different shear rates, temperatures, and drug contents. The following are the main problems and objectives of the paper:

1. **Optimizing the manufacturing process**: Melt viscosity is a key property in the pharmaceutical manufacturing process (such as mixing, extrusion, fused deposition modeling, and melt coating). By accurately measuring and modeling the melt viscosity of these mixtures, the manufacturing process can be optimized to ensure its smooth progress.

2. **Understanding the influencing factors**: The research aims to systematically analyze the effects of shear rate, temperature, and drug proportion on melt viscosity. This is crucial for developing effective mathematical models.

3. **Establishing a general model**: Based on experimental data, the author proposes a general model to describe the melt viscosity of drug/polymer mixtures, taking into account factors such as shear rate, temperature, and drug content. This will help predict the melt behavior under different conditions and thus find the optimal processing parameters.

### Specific problems and solutions

- **Selecting materials**: Three different polymers (Eudragit EPO, Soluplus, and Plasdone S - 630) and three commonly used drugs (acetaminophen, itraconazole, and griseofulvin) were selected. These materials are widely used in processes such as hot - melt extrusion, so the results are representative.

- **Experimental methods**: The melt viscosity was measured using rotational and oscillatory rheometers, and samples were prepared by vacuum compression molding to ensure the uniformity and repeatability of the samples.

- **Data analysis**: For pure polymers, the Carreau and Arrhenius models were used to describe their shear - thinning behavior and temperature dependence. For drug/polymer mixtures, a "drug shift factor" was introduced to describe the effect of drug content on viscosity.

### Key formulas

1. **Cox - Merz rule**:
\[
\eta(\dot{\gamma}) = |\eta^*(\omega)|
\]
This rule indicates that the dynamic viscosity and the complex viscosity are interchangeable under certain conditions.

2. **Carreau model**:
\[
\eta(\dot{\gamma}) = \eta_0 \left( 1 + \left( \frac{\dot{\gamma}}{\dot{\gamma}_c} \right)^2 \right)^{\frac{c}{2}}
\]
where $\eta_0$ is the zero - shear - rate viscosity, $\dot{\gamma}_c$ is the critical shear rate, and $c$ is the flow index.

3. **Arrhenius equation**:
\[
a_T(T, T_{ref}) = \frac{\eta_0(T)}{\eta_0(T_{ref})} = \exp \left( \frac{E_A}{R} \left( \frac{1}{T} - \frac{1}{T_{ref}} \right) \right)
\]
where $a_T$ is the temperature shift factor, $E_A$ is the activation energy, and $R$ is the ideal gas constant.

4. **Combining the Carreau and Arrhenius models**:
\[
\eta(\dot{\gamma}, T) = \eta_0 \cdot a_T(T, T_{ref}) \left( 1 + a_T(T, T_{ref}) \cdot \frac{\dot{\gamma}}{\dot{\gamma}_c} \right)^{\frac{c}{2}}
\]

Through these models and methods, the author successfully established a general model for describing the melt viscosity of drug/polymer mixtures, providing a theoretical basis for subsequent research and applications.